Key result
A permanently implantable direct left atrial pressure monitoring system was feasible and accurate, with 87% of measurements within ±5 mm Hg of simultaneous wedge pressure at 12 weeks.
Why the study?
Is a permanently implantable direct left atrial pressure monitoring system feasible, safe, and accurate in ambulatory patients with chronic heart failure?
Population
8 ambulatory patients with established chronic heart failure and at least 1 heart failure hospitalization or…
Design
Case_series
Follow-up
12 weeks
Authors
Loading...
Implantable LAP monitoring is feasible in ambulatory HF; leaves open whether LAP-guided therapy improves outcomes.
Is a permanently implantable direct left atrial pressure monitoring system feasible, safe, and accurate in ambulatory patients with chronic heart failure?
A novel permanently implantable direct left atrial pressure monitoring system is feasible, safe, and accurate compared to right heart catheterization at 12 weeks in ambulatory heart failure patients.
Ritzema et al. (2007) studied chronic heart failure (n=8). Permanently implantable, direct left atrial pressure (LAP) monitoring system was evaluated on Device LAP measurements within +/-5 mm Hg of simultaneous pulmonary capillary wedge pressure readings. A permanently implantable direct left atrial pressure monitoring system was feasible and accurate, with 87% of measurements within ±5 mm Hg of simultaneous wedge pressure at 12 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: